Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Starr

Showing results (251-260 of 259) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 259 results.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II TrialDaniel H Ahn, Maya Ridinger, Timothy L Cannon, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
Rare Tumors|October 5, 2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell SarcomaJaime I Davila, Jason S Starr, Steven Attia, et al.
Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.
Pharmacotherapy|September 12, 2023
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trialScott A Mosley, Emily Cicali, Alex Del Cueto, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Pageof 26

Showing results (251-260 of 259) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
JCO Precision Oncology|March 25, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal CarcinomaFares Jamal, Oudai Sahwan, Seyi Abidoye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of <i>KRAS</i>-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II TrialDaniel H Ahn, Maya Ridinger, Timothy L Cannon, et al.
The Journal of Infectious Diseases|May 1, 1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupR J Whitley, G Cloud, W Gruber, et al.
Rare Tumors|October 5, 2017
Comprehensive Genomic Profiling of a Rare Thyroid Follicular Dendritic Cell SarcomaJaime I Davila, Jason S Starr, Steven Attia, et al.
Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.
Pharmacotherapy|September 12, 2023
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trialScott A Mosley, Emily Cicali, Alex Del Cueto, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
JCO Precision Oncology|June 6, 2022
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based ChemotherapyPedro Luiz Serrano Uson Junior, Umair Majeed, Jun Yin, et al.
Pageof 26